NCT06206044View on ClinicalTrials.gov

Evaluation of the Typical Spinal Block During Cesarean Delivery

Enrolling by invitationOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

June 10, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions
Cesarean SectionAnesthesia, Obstetric
Interventions
DRUG

Intrathecal 1.6 ml 0.75% bupivacaine in 8.25% dextrose combined with 15 mcg fentanyl and 150 mcg preservative-free morphine

Patients will receive standard intrathecal medications for urgent and scheduled cesarean delivery at the study site. All study subjects will receive bupivacaine, fentanyl, and morphine.

Trial Locations (1)

97239

Oregon Health and Science University, Portland

All Listed Sponsors
lead

Oregon Health and Science University

OTHER